MYC and Familial prostate cancer: VPC-70063 affected the Myc-Max AR-V7/UBE2C downstream pathway showing the highest reduction of levels of the constitutively active ligand-independent androgen receptor splice variant AR-V7 that promotes advanced castration-resistant prostate cancer [148,149], in androgen-deprived 22rv1 cells.